Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フ

Japan's day, wrapped and delivered by morning.

Article

Toho Acetylene says growth spending will keep ROE below target as it chases a 1x book multiple

Management says ROE in the year to March 2026 was 6.87% against a PBR of 0.80x, above its rough 6% equity-cost estimate but still short of its 8% goal. The company is prioritising investment over a cosmetic fix, targeting operating profit of ¥2.4bn and net profit of ¥1.6bn by 2028 while saying ROE is only expected to improve to 7.6% during the current plan.

Jun 25, 20262 min read
Editorial illustration of industrial gas equipment and delivery assets with a valuation gauge moving toward 1x book value.

Toho Acetylene has given investors a fairly direct explanation for why its shares are still below book value: last year's ROE cleared the company's roughly 6% estimate of shareholder equity cost, but it still fell short of the 8% level management wants, and the company says it has not explained its corporate value and growth strategy clearly enough to the market.

In the year to March 2026, sales were ¥34.6bn, operating profit was ¥1.9bn and net profit was ¥1.3bn. ROE came in at 6.87%, down from 7.19% a year earlier, while PBR was 0.80x. Management says higher repair costs linked to pricier raw materials and supplies, plus higher logistics and labour costs, offset efforts to strengthen existing businesses and expand business areas. It also says expansion through M&A fell short, leaving ordinary profit and net profit roughly flat and not enough to raise ROE.

Capital-efficiency scorecard
Figures and targets disclosed in Toho Acetylene's management update.
MetricLatest or planManagement reference
ROE in the year to March 20266.87%Above roughly 6% equity cost, below 8% target
PBR0.80xAim is 1x or above over the medium to long term
ROE during current midterm plan7.6% expectedLarge growth investment takes priority
Operating profit target by 2028¥2.4bnPart of the new midterm plan
Net profit target by 2028¥1.6bnPart of the new midterm plan
Dividend payout ratio during the plan40% guidelineBalanced with internal reserves and investment

Investment first

The more interesting part of the update is that management is not promising a quick numerical fix. Under the midterm plan it disclosed on June 9, Toho Acetylene is targeting operating profit of ¥2.4bn and net profit of ¥1.6bn by 2028, but says ROE will improve only to 7.6% during the plan because large equipment spending and supply-infrastructure reinforcement come first. Its medium- to long-term aim remains ROE of 8% and a PBR of 1x or above.

The investment list is concrete. The company plans to improve utilisation of hydrogen production equipment and expand sales to semiconductor-related customers, build a new food-additive gas filling plant due for completion in January 2027, and open a new factory for its ice-machine-related business in May 2027.

Returns and the messaging problem

Management is pairing that spending with a dividend payout guideline of 40% during the plan, while balancing retained earnings for business expansion, earnings-base strengthening and capital expenditure. It also says it will step up investor outreach through institutional briefings led by executives, retail-investor IR fairs, more one-on-one engagement with analysts and investors, fuller web and media disclosures, and richer integrated-report content.

For investors, the useful signal is the sequence: investment first, clearer messaging alongside it, and only then a hoped-for move above 1x book. Toho Acetylene is being explicit that the near-term ROE math still does not get it to the 8% line it wants.